HIF prolyl hydroxylase PHD3 maintains hypoxic cell cycle through cyclin-dependent kinase inhibitor P27

: Hogel H, Miikkulainen P, Bino L, Jaakkola PM

Publisher: ELSEVIER SCI LTD

: 2014

: European Journal of Cancer

: EUROPEAN JOURNAL OF CANCER

: EUR J CANCER

: 50

: Suppl. 5

: S51

: S51

: 1

: 0959-8049

DOI: https://doi.org/10.1016/S0959-8049(14)50194-3